Garuda Therapeutics

Creating off-the-shelf, long-term durable blood stem cell therapies

[Garuda Therapeutics @GarudaTx]

We are pleased to announce that Garuda’s CEO @ShahDhvanit will be presenting at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022.

[Garuda Therapeutics @GarudaTx]

Dr. Roger Sawhney named CFO & joins team that seeks to eliminate the dependency on donor or patient cells for blood stem cell transplants. https://t.co/kea8JeNhFZ

[Garuda Therapeutics @GarudaTx]

Recently the Garuda team gathered for golf, games and good food to celebrate the end of summer! Thanks to @TheKimballFarm for having us!

[Garuda Therapeutics @GarudaTx]

We are excited to announce that biotech veteran James Desiderio has joined #GarudaTx as Chief Regulatory Officer. https://t.co/rdR4AqGGqp

[Garuda Therapeutics @GarudaTx]

We are pleased to introduce Denise Morad! Welcome to #GarudaTx.

[Garuda Therapeutics @GarudaTx]

Welcome to the team, Yugang! We are thrilled to have you. #GarudaTx

[Garuda Therapeutics @GarudaTx]

#GarudaTx is excited to introduce another member of our team, Zhi-Jian (Albert) Liu. Welcome to Garuda!

[Garuda Therapeutics @GarudaTx]

We are pleased to present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022 at 5.30 pm EST. We look forward to connecting with you! https://t.co/V1c7YtBVq5 #JPM22 #JPM2022

[Garuda Therapeutics @GarudaTx]

We are pleased to announce that biopharma veteran & current @DecibelTx CEO, @laurence_reid, Ph.D., has joined Garuda’s Board of Directors. https://t.co/V1c7YtTwOF

[Garuda Therapeutics @GarudaTx]

Garuda’s team is growing! We are looking for a qualified stem cell transplantation specialist to join us in developing off-the-shelf HSC-based therapies. Learn more about this position and apply here: https://t.co/LtTct6aCkQ #GarudaTx

[Garuda Therapeutics @GarudaTx]

Meet Giorgia Scapin, our Vice President of R&D. We are thrilled to have you on the #GarudaTx team!

[Garuda Therapeutics @GarudaTx]

#GarudaTX is thrilled to introduce Marie Goulard, Director of R&D. Welcome to the team, Marie!

[Garuda Therapeutics @GarudaTx]

We are excited to introduce another member of our team. Meet Rossana Serpe, a Postdoctoral Scientist at #GarudaTx

[Garuda Therapeutics @GarudaTx]

We are excited to introduce our team! Meet Matthew Algarin, our Vivarium Manager. #GarudaTx

[Garuda Therapeutics @GarudaTx]

A recent @NIH feature details the promise of #GarudaTx’s revolutionary blood stem cell technology. Partially funded by #NHBLI, our research is striving to create the world’s first off-the-shelf bloom stem cell platform. Learn more: https://t.co/GbZIZJmUyO

[Garuda Therapeutics @GarudaTx]

“Shah believes the tech could simplify and democratize access to #CellTherapy, which is currently a time-intensive, expensive process that requires patients to stay in a hospital for several days,” Walrath writes in her @BBJ article on Garuda’s launch. https://t.co/6enkzqg3J9

[Garuda Therapeutics @GarudaTx]

We’re excited to announce the launch of Garuda Therapeutics with $72 million in Series A financing. Co-founded by @ShahDhvanit, Kiran Reddy, David Scadden, and @SJMorrison_, Garuda is committed to changing the world of blood stem cell transplants. More @ https://t.co/3uRAptMLM1